Stockreport

Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com
PDF Represents the Fourth Innovus Pharma Product Notification in the E.U. SAN DIEGO--(BUSINESS WIRE)-- Innovus Pharmaceuticals, Inc. ("Innovus Pha [Read more]